Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Basal levels of max are sufficient for the cotransformation of C3H10T1/2 cells by ras and myc.

Davenport EA, Taparowsky EJ.

Exp Cell Res. 1992 Oct;202(2):532-40.

PMID:
1397104
2.

Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.

Cerni C, Bousset K, Seelos C, Burkhardt H, Henriksson M, Lüscher B.

Oncogene. 1995 Aug 3;11(3):587-96.

PMID:
7630643
5.

Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.

Mäkelä TP, Koskinen PJ, Västrik I, Alitalo K.

Science. 1992 Apr 17;256(5055):373-7.

PMID:
1566084
6.

Oncogene-mediated multistep transformation of C3H10T1/2 cells.

Taparowsky EJ, Heaney ML, Parsons JT.

Cancer Res. 1987 Aug 1;47(15):4125-9.

7.

A role for myn in Ha-ras transformation of mouse 10T1/2 fibroblasts.

Taylor WR, Wright JA.

Mol Carcinog. 1994 May;10(1):8-14.

PMID:
8185831
8.
9.
10.

Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.

Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV.

Mol Cell Biol. 1992 Jul;12(7):3130-7.

11.

HMG-I/Y, a new c-Myc target gene and potential oncogene.

Wood LJ, Mukherjee M, Dolde CE, Xu Y, Maher JF, Bunton TE, Williams JB, Resar LM.

Mol Cell Biol. 2000 Aug;20(15):5490-502.

12.

Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.

Hurlin PJ, Quéva C, Koskinen PJ, Steingrímsson E, Ayer DE, Copeland NG, Jenkins NA, Eisenman RN.

EMBO J. 1995 Nov 15;14(22):5646-59. Erratum in: EMBO J. 1996 Apr 15;15(8):2030.

13.

MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc.

Niki T, Izumi S, Saëgusa Y, Taira T, Takai T, Iguchi-Ariga SM, Ariga H.

Genes Cells. 2000 Feb;5(2):127-41.

14.

Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions.

Prendergast GC, Hopewell R, Gorham BJ, Ziff EB.

Genes Dev. 1992 Dec;6(12A):2429-39.

15.

Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.

Koskinen PJ, Ayer DE, Eisenman RN.

Cell Growth Differ. 1995 Jun;6(6):623-9.

16.

Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype.

Schreiber-Agus N, Stein D, Chen K, Goltz JS, Stevens L, DePinho RA.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1235-40.

17.
18.

Cooperation of oncogenes in the multistep transformation of established fibroblasts in culture.

Davenport EA, Drobes BL, Menke SL, Vaidya TB, Taparowsky EJ.

Anticancer Res. 1988 Sep-Oct;8(5A):959-69.

PMID:
2845855
19.

Oncogenic activity of the c-Myc protein requires dimerization with Max.

Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H.

Cell. 1993 Jan 29;72(2):233-45.

PMID:
8425220
20.

The Adrenomedullin gene is a target for negative regulation by the Myc transcription complex.

Wang X, Peters MA, Utama FE, Wang Y, Taparowsky EJ.

Mol Endocrinol. 1999 Feb;13(2):254-67.

PMID:
9973255

Supplemental Content

Support Center